Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Trends Cardiovasc Med. 2013 Jan;23(1):1-4. doi: 10.1016/j.tcm.2012.08.002. Epub 2012 Aug 29.
Angiogenesis is a crucial process whereby new blood vessels are formed from pre-existing vessels, and it occurs under both normal and pathophysiological conditions. The process is precisely regulated through the balance between proangiogenic and anti-angiogenic mechanisms, and many of these mechanisms have been well-characterized through extensive research. However, little is known about how angiogenesis is regulated at the transcriptional level. We have recently shown that deletion of the Forkhead box (Fox) transcription factor Foxc1 in cells of neural crest (NC) lineage leads to aberrant vessel growth in the normally avascular corneas of mice, and that the effect is cell type-specific because the corneas of mice lacking Foxc1 expression in vascular endothelial cells remained avascular. The NC-specific Foxc1 deletion was also associated with elevated levels of both proangiogenic factors, such as the matrix metalloproteases (MMPs) MMP-3, MMP-9, and MMP-19 and the angiogenic inhibitor soluble vascular endothelial growth factor receptor 1 (sVEGFR-1). Thus, FoxC1 appears to control angiogenesis by regulating two distinct and opposing mechanisms; if so, vascular development could be determined, at least in part, by a competitive balance between proangiogenic and anti-angiogenic FoxC1-regulated pathways. In this review, we describe the mechanisms by which FoxC1 regulates vessel growth and discuss how these observations could contribute to a more complete understanding of the role of FoxC1 in pathological angiogenesis.
血管生成是一个新的血管从预先存在的血管形成的关键过程,它发生在正常和病理生理条件下。这个过程是通过促血管生成和抗血管生成机制之间的平衡来精确调节的,许多这些机制已经通过广泛的研究得到了很好的描述。然而,对于血管生成是如何在转录水平上调节的,人们知之甚少。我们最近表明,在神经嵴(NC)谱系的细胞中缺失叉头框(Fox)转录因子 Foxc1 会导致小鼠正常无血管角膜中的血管生长异常,并且这种效应是细胞类型特异性的,因为缺乏 Foxc1 在血管内皮细胞中表达的小鼠角膜仍然无血管。NC 特异性 Foxc1 缺失也与促血管生成因子水平升高有关,如基质金属蛋白酶(MMPs)MMP-3、MMP-9 和 MMP-19 以及血管生成抑制剂可溶性血管内皮生长因子受体 1(sVEGFR-1)。因此,FoxC1 似乎通过调节两种截然不同的、相反的机制来控制血管生成;如果是这样,血管发育至少在一定程度上可以由促血管生成和抗血管生成 FoxC1 调节途径之间的竞争平衡来决定。在这篇综述中,我们描述了 FoxC1 调节血管生长的机制,并讨论了这些观察结果如何有助于更全面地了解 FoxC1 在病理性血管生成中的作用。